{"entity":{"type":"insider","cik":"0001403571","url":"/insider/0001403571","json_url":"/insider/0001403571.json","name":"Turner Heather D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":6,"first":"2012-07-19","last":"2018-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Turner Heather D","source":"filing","n_filings":6,"first_seen":"2012-07-19","last_seen":"2018-02-12"}],"transactions":[{"id":6491775,"accession":"0001209191-18-009413","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-009413","line_url":"/filing/0001209191-18-009413","is_derivative":false,"issuer_cik":"0001403571","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001403571","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (Former EVP, GC & Sec)","role_mark":"O","role_mark_label":"Officer (Former EVP, GC & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Former EVP, GC & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12214.0,"shares_display":"12,214","price_per_share":38.00636810217783,"price_display":"38.01","price_state":"stated","total_value":464209.78,"total_display":"464,209.78","total_whole":"464,210","shares_owned_after":77112.0,"shares_owned_after_display":"77,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-09","filed_date":"2018-02-12","scope":"insider","n_lines":6},{"id":5341556,"accession":"0001209191-17-009533","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-009533","line_url":"/filing/0001209191-17-009533","is_derivative":false,"issuer_cik":"0001403571","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001403571","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (EVP, General Counsel & Sec)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel & Sec)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel & Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12215.0,"shares_display":"12,215","price_per_share":15.723837904216127,"price_display":"15.72","price_state":"stated","total_value":192066.68,"total_display":"192,066.68","total_whole":"192,067","shares_owned_after":86775.0,"shares_owned_after_display":"86,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-10","scope":"insider","n_lines":2},{"id":6786847,"accession":"0001181431-14-037956","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-037956","line_url":"/filing/0001181431-14-037956#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22643.0,"shares_display":"22,643","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":135858.0,"total_display":"135,858.00","total_whole":"135,858","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-04","scope":"insider"},{"id":6730191,"accession":"0001181431-14-037422","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-14-037422","line_url":"/filing/0001181431-14-037422#line-4","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7382.0,"shares_display":"7,382","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":44292.0,"total_display":"44,292.00","total_whole":"44,292","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-26","scope":"insider"},{"id":6730185,"accession":"0001181431-14-037422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-037422","line_url":"/filing/0001181431-14-037422#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24006.0,"shares_display":"24,006","price_per_share":5.773,"price_display":"5.77","price_state":"stated","total_value":138586.638,"total_display":"138,586.64","total_whole":"138,587","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-26","scope":"insider"},{"id":6585449,"accession":"0001181431-14-032492","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-032492","line_url":"/filing/0001181431-14-032492#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (VP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (VP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300000.0,"shares_display":"300,000","price_per_share":4.465,"price_display":"4.46","price_state":"stated","total_value":1339500.0,"total_display":"1,339,500.00","total_whole":"1,339,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-22","filed_date":"2014-09-22","scope":"insider"},{"id":3544894,"accession":"0001181431-12-041387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-041387","line_url":"/filing/0001181431-12-041387#line-2","is_derivative":false,"issuer_cik":"0001382911","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001382911","owner_cik":"0001403571","owner_name":"Turner Heather D","owner_display_name":"Turner Heather D","owner_url":"/insider/0001403571","role":"Officer (SVP, Gen. Counsel & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, Gen. Counsel & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Gen. Counsel & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82433.0,"shares_display":"82,433","price_per_share":7.6844,"price_display":"7.68","price_state":"stated","total_value":633448.1452,"total_display":"633,448.15","total_whole":"633,448","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-17","filed_date":"2012-07-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (Former EVP, GC & Sec)","n_filings":2,"first_seen":"2017-02-10","last_seen":"2018-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Officer (SVP, Gen. Counsel & Secretary)","n_filings":4,"first_seen":"2012-07-19","last_seen":"2014-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001403571","retrieved_at":"2026-08-26T07:51:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}